Juno Therapeutics
Sana Biotechnology is set to start trading on Thursday.
The secretive Seattle-based biotech had raised $705.5 million since it was founded in July 2018.
We dug through its 271-page filing to unearth five key details on the Sana s financials, strategy, and future.
After raising more than $700 million since its 2018 launch, one of the biotech industry s most valuable private companies is set to start trading on Thursday.
Seattle-based Sana Biotechnology filed paperwork on January 14 for an initial public offering. Following a red-hot year for biotech IPOs in 2020, Sana is hoping to take advantage of investor enthusiasm to fuel its ambitious cell and gene therapy programs.
BioSpace Announces Top New Life Sciences Companies to Watch in 2021
News provided by
Share this article
Share this article
DES MOINES, Iowa, Jan. 6, 2021 /PRNewswire/ BioSpace, Inc., the leading life sciences news and careers site, has announced their 25 selections for biopharma s most promising up-and-coming companies in 2021.
For the past seven years, BioSpace has been honoring the most innovative new biopharma companies from across the U.S. The
NextGen Bio list has been noted for anticipating organizations on their way to success.
Topping the
NextGen Bio Class of 2021 list is Sana Biotechnology, developer of accessible gene and cell therapy solutions. Having raised $700 million in June, Sana has since acquired Oscine Corp
Top Life Sciences Startups to Watch in 2021 biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.